Treatment Of Hepg2 Cell Lines With Ato And Sorafenib Results In

Treatment of HepG2 cell lines with ATO and Sorafenib results in ...
Treatment of HepG2 cell lines with ATO and Sorafenib results in ...
Effects of sorafenib and ATRA on GJIC activity in HCC cell lines. HepG2 ...
Effects of sorafenib and ATRA on GJIC activity in HCC cell lines. HepG2 ...
Combination treatment of lonafarnib and sorafenib inhibits HepG2 cell ...
Combination treatment of lonafarnib and sorafenib inhibits HepG2 cell ...
ATO treatment of HepG2 cells results in sustained activation of MAPK ...
ATO treatment of HepG2 cells results in sustained activation of MAPK ...
VEGF released by HCC cell lines in sorafenib and dasatinib treatment ...
VEGF released by HCC cell lines in sorafenib and dasatinib treatment ...
Effects of treatment with CRET and/or sorafenib on HepG2 cell ...
Effects of treatment with CRET and/or sorafenib on HepG2 cell ...
Effects of sorafenib and ATRA on the growth inhibition in HCC cell ...
Effects of sorafenib and ATRA on the growth inhibition in HCC cell ...
Effects of the sorafenib treatment on HCC cell lines. The HepG2 ...
Effects of the sorafenib treatment on HCC cell lines. The HepG2 ...
Dose–response effects of sorafenib on different cell lines. HepG2 and ...
Dose–response effects of sorafenib on different cell lines. HepG2 and ...
Combination treatment of sorafenib and epalrestat inhibited HepG2 ...
Combination treatment of sorafenib and epalrestat inhibited HepG2 ...
Dose–response effects of sorafenib on different cell lines. HepG2 and ...
Dose–response effects of sorafenib on different cell lines. HepG2 and ...
Uptake of sorafenib in control and transgenic HepG2 and LO2 cells ...
Uptake of sorafenib in control and transgenic HepG2 and LO2 cells ...
The anti-cancer effect of the combined treatment with sorafenib and ...
The anti-cancer effect of the combined treatment with sorafenib and ...
Inhibition Effects of CuD, CuI, and sorafenib on HepG2 and L929 cell ...
Inhibition Effects of CuD, CuI, and sorafenib on HepG2 and L929 cell ...
Cell death assessment and involvement of HIFs in sorafenib resistant ...
Cell death assessment and involvement of HIFs in sorafenib resistant ...
Combined treatment with sorafenib and VK2 inhibits HCC cell growth. (A ...
Combined treatment with sorafenib and VK2 inhibits HCC cell growth. (A ...
Cell viability of HepG2 cells treated with Sorafenib loaded casein ...
Cell viability of HepG2 cells treated with Sorafenib loaded casein ...
Sorafenib treatment in liver cells, hepatoma cells, and plectin ...
Sorafenib treatment in liver cells, hepatoma cells, and plectin ...
Effects of Sorafenib on cell proliferation differ between HepG2 cells ...
Effects of Sorafenib on cell proliferation differ between HepG2 cells ...
Sunitinib and sorafenib induce the apoptosis of human HepG2 and ...
Sunitinib and sorafenib induce the apoptosis of human HepG2 and ...
Effects of sorafenib on cell viability and histone deacetylase (HDAC ...
Effects of sorafenib on cell viability and histone deacetylase (HDAC ...
In vivo activity of sorafenib and capsaicin in stem‐like cells. (A) The ...
In vivo activity of sorafenib and capsaicin in stem‐like cells. (A) The ...
EGF and IGF counteract the inhibitory effect of Sorafenib. HepG2 cell ...
EGF and IGF counteract the inhibitory effect of Sorafenib. HepG2 cell ...
HMGB1 is upregulated in HepG2 cells following sorafenib treatment (*p
HMGB1 is upregulated in HepG2 cells following sorafenib treatment (*p
Cytotoxic effects of Sorafenib and combination on HepG2 cells following ...
Cytotoxic effects of Sorafenib and combination on HepG2 cells following ...
Effect of sorafenib on the motility and MMP-2 expression of HepG2 and ...
Effect of sorafenib on the motility and MMP-2 expression of HepG2 and ...
Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect ...
Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect ...
Effects of sorafenib on cell proliferation in human hepatoma cell ...
Effects of sorafenib on cell proliferation in human hepatoma cell ...
Combination treatment of sorafenib and epalrestat activated autophagy ...
Combination treatment of sorafenib and epalrestat activated autophagy ...
| Maprotiline in combination with sorafenib inhibits the growth of Huh7 ...
| Maprotiline in combination with sorafenib inhibits the growth of Huh7 ...
(a) Apoptosis analysis of RNA lentivirus infected HepG2 with sorafenib ...
(a) Apoptosis analysis of RNA lentivirus infected HepG2 with sorafenib ...
Suppression of HMGB1 increases the sensitivity to sorafenib in HepG2 ...
Suppression of HMGB1 increases the sensitivity to sorafenib in HepG2 ...
The combined treatment of sorafenib and c-Myc inhibitor EN4 inhibits ...
The combined treatment of sorafenib and c-Myc inhibitor EN4 inhibits ...
The dose-escalating assays of sorafenib treatment in reducing the ...
The dose-escalating assays of sorafenib treatment in reducing the ...
(a) Cell viability of HepG2 (control) and miR-148a mimic-transfected ...
(a) Cell viability of HepG2 (control) and miR-148a mimic-transfected ...
Combination treatment with metformin and sorafenib synergistically ...
Combination treatment with metformin and sorafenib synergistically ...

Loading image details...

Source
Dimensions